The ?Shineway? trademark was awarded ?China Famous Trademark? in 2002.  In January 2003, Shineway passed the GMP certification of all phases by the State.  Shineway is the first ever proprietary Chinese medicine enterprise in China who obtained the Integrated Management Systems certificate (IMS) from British Standards International (BSI) in July 2004.  It is comprised of ISO9001 of international quality management and quality assurance in production, ISO14001 of international standard for controlling and improving environmental performance, and OHSAS18001 of occupational health and safety assessment series 18000.  The shares of Shineway were listed on the Main Board of the Stock Exchange of Hong Kong on 2 December 2004.  It has become one of the top 200 listed companies in terms of market capitalization.  In October 2005, Shineway was ranked one of the ?Top 10 Most Profitable Enterprises of Chinese Medicine Manufacturing Industry in China?, released by the National Bureau of Statistics of China.
Shineway produces products aiming at the segments of treatment of diseases commonly affecting middle and old aged people and/or children, and anti-viral treatment; and leverages the advantages of developing modern Chinese medicine of soft capsule, granule and injection dose forms.  Shineway is the production base of the largest scale of the state-of-the-art technology producing soft capsule and injection of modern Chinese medicines.  The company is manufacturing 9 dose forms of more than 200 items.  Among all these, Wufu Xinnao Kang Soft Capsule, Qingkailing Soft Capsule, Liyan Jiedu Granule, Jieyu Anshen Granule, Nailibao Pill, etc., of almost 50 items are exporting to more than 10 foreign countries and regions globally.